NCT00161733

Timeline

Start date

Sep 1, 2002

Primary completion

—

Completion date

Nov 1, 2004

First posted

—

Last posted

—

Enrollment

—

Arms / groups

— / —

Source

AACT · pre-existing

Sponsors

• BaxaltaLead sponsor
• SentaraOverall official - principal investigator
• University of California, IrvineOverall official - principal investigator
• University of FloridaOverall official - principal investigator
• University of MichiganOverall official - principal investigator
• Peachtree Cardiovascular, Atlanta, GAOverall official - principal investigator
• Brevard Cardio Surgeons/Health First Heart Institute, Melbourne, FLOverall official - principal investigator
• Franciscan Health System Research Center, Tacoma, WAOverall official - principal investigator
• Harvard UniversityOverall official - principal investigator
• University of VirginiaOverall official - principal investigator
• Duke UniversityOverall official - principal investigator
• University of ChicagoOverall official - principal investigator
• University of KentuckyOverall official - principal investigator
• University of Medicine and Dentistry of New JerseyOverall official - principal investigator
• University of CincinnatiOverall official - principal investigator
• Baylor UniversityOverall official - principal investigator
• Washington University in St. LouisOverall official - principal investigator
• Lenox Hill HospitalOverall official - principal investigator
• The Oregon ClinicOverall official - principal investigator
• University of ArizonaOverall official - principal investigator
• University of RochesterOverall official - principal investigator
• University of MassachusettsOverall official - principal investigator

Drugs studied

• human fibrin

Indications studied

• Cardiopulmonary Bypass
• General Surgery
• Sternotomy